Valuation: Becton, Dickinson and Company

Market Cap 58.68B 53.51B 49.48B 44.65B 84.1B 5,483B 87.41B 598B 236B 2,960B 220B 216B 9,346B P/E 2026
43.8x
P/E 2027 * 29.3x
Enterprise Value 74.56B 68B 62.87B 56.74B 107B 6,968B 111B 759B 300B 3,761B 280B 274B 11,876B EV / Sales 2026
3.31x
EV / Sales 2027 * 3.71x
Free-Float
73.17%
Yield 2026 *
1.94%
Yield 2027 * 1.94%
1 day+0.48%
1 week+0.88%
Current month+9.36%
1 month+13.46%
3 months+19.71%
6 months+52.02%
Current year+11.51%
1 week 212.76
Extreme 212.755
220.36
1 month 189.49
Extreme 189.49
220.36
Current year 140.11
Extreme 140.11
220.36
1 year 140.11
Extreme 140.11
220.36
3 years 140.11
Extreme 140.11
251.98
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Chief Tech/Sci/R&D Officer 56 2023-12-03
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
10/26/26 Sell

Executive/Senior Manager

-76 0.0000%
9/28/26 Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 Tax

Chief Financial Officer

-190 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%+0.88%+12.52%-7.39% 58.68B
+0.13%-4.35%-19.58%+3.30% 181B
-1.42%-0.95%-0.16%+33.90% 125B
-0.03%-0.44%-11.72%+9.71% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-0.57%-0.49%-3.73%+77.68% 66.9B
+1.42%-0.23%+4.59%+48.22% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+4.77%+3.97%-1.08% 35.4B
+3.87%-7.39% - - 33.11B
Average +0.70%-0.90%-6.43%+22.82% 81B
Weighted average by Cap. +0.27%-1.61%-10.23%+19.77%

Financials

2026 2027 *
Net sales 19.29B 17.59B 16.27B 14.68B 27.65B 1,803B 28.74B 196B 77.66B 973B 72.37B 70.85B 3,072B 19.78B 18.04B 16.68B 15.05B 28.35B 1,848B 29.46B 201B 79.62B 998B 74.2B 72.65B 3,150B
Net income 1.41B 1.28B 1.19B 1.07B 2.02B 131B 2.09B 14.32B 5.66B 70.93B 5.28B 5.17B 224B 2.01B 1.83B 1.7B 1.53B 2.88B 188B 2.99B 20.47B 8.09B 101B 7.54B 7.38B 320B
Net Debt 15.88B 14.49B 13.39B 12.09B 22.77B 1,484B 23.66B 162B 63.95B 801B 59.59B 58.35B 2,530B 14.63B 13.34B 12.33B 11.13B 20.96B 1,367B 21.79B 149B 58.89B 738B 54.88B 53.73B 2,330B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
60,000
Date Price Change Volume
26-11-18 $216.49 +0.49% 814,660
26-11-17 $215.42 -0.49% 2,307,415
26-11-16 $216.47 -0.72% 1,498,404
26-11-13 $218.03 +1.08% 1,879,909
26-11-12 $215.71 +0.55% 1,762,438
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
215.42USD
Average target price
226.14USD
Spread / Average Target
+4.98%